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Abstract
Background: Liver transplantation (LT) accompanied by jejunectomy to treat patients with acute or chronic hepatic
cirrhosis with thrombosis in the portal system is extremely rare.
Case presentation: A 47-year-old man presented with hematemesis and melena, and a diagnosis of decompensated
cirrhosis, chronic portal vein thrombosis (PVT) and secondary gastro-esophageal variceal hemorrhage was made.
Coagulants were administered, but portal vein thrombi occurred rapidly, and gastrointestinal bleeding recurred shortly
thereafter. The patient underwent LT, phlebothrombectomy and a partial jejunectomy. His recovery from a fistula was
uneventful, and follow-up visits over 70 months were unremarkable.
Conclusion: Liver transplantation and partial jejunectomy is a feasible and effective surgical option for select patients
with end-stage liver disease accompanied by acute portal venous thrombosis.
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Background
Chronic portal vein thrombosis (PVT) is a vascular dis-
ease that commonly occurs in end-stage liver disease pa-
tients waiting for liver transplantation (LT), and it causes
challenges for transplant specialists. Nearly three de-
cades ago, advanced cirrhosis and PVT were contraindi-
cations for liver transplantation because of surgical
technique limitations. In 1985, Shaw et al. first reported
using a venous graft conduit to bypass the thrombotic
segmental vessel to successfully overcome surgical limi-
tations during LT [1].
More clinical cases were subsequently reported about
this entity because of imaging technology progress, such
as ultrasound, computerized tomography and magnetic
resonance that can detect disease alone or in combin-
ation before transplantation [2]. Its prevalence in ortho-
topic liver transplantation candidates ranged from 2.1 to
21 % [3–5].
Thrombi in the main portal vein can extend to differ-
ent splanchnic veins because of predisposing factors.
Based on how rapidly PVT and collateral veins develop,
PVT was clinically classified as either acute or chronic
[6–8]. If there is a lack of collateral veins, thrombosis
develops quickly and results in congestive ischemia and
subsequent gut necrosis, which are typical clinical pre-
sentations of acute PVT. However, chronic PVT, which
is more common, is almost asymptomatic and develops
over months or years. Yerdle et al. graded 4 forms of
chronic PVT based on the extent of occlusion and mes-
enteric veins involved [9], and many surgical strategies
had been subsequently developed to revascularize the
maintain blood flow to the transplanted liver [10–12].
There have been no cases of LT candidates with acute
PVT that is accompanied by intestinal necrosis. Here,
we present the first case of a patient with acute-on-
chronic PVT with intestinal necrosis that occurred dur-
ing LT that was used to treat end-stage liver cirrhosis.
Case presentation
A 47-year-old male patient was admitted with esophago-
gastric hemorrhage secondary to portal hypertension
derived from decompensated cirrhosis. At the initial
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consultation, his chief complaint was hematemesis and
two episodes of melena. His past medical history was
viral hepatitis B with HBsAg + and HBcAb + for more
than 10 years, and his surgical history included sple-
nectomy and periesophagogastric devascularization for
portal hypertension, hypersplenism and splenomegaly,
and cholecystectomy for gallstones one year before, at a
different hospital. His vital signs were as follows:
temperature, 36.7 °C; blood pressure, 120/68 mmHg;
respiratory rate, 20; and heart rate, 84. He had scleral ic-
terus in both eyes. Physical examination showed negative
chest and cardiac findings. Tenderness and rebound pain
was marked, and shift dullness was remarkable. His
blood work results were as follows: white blood cell
count, 16.6 × 109/l; red blood cell count, 2.47 × 1012/l;
platelet cell count, 183 × 109/l; and hemoglobin, 67 g/l.
Stool hemoccult test results were positive (+++). His liver
function profile was as follows: total bilirubin, 84 μmol/l;
ALT, 319; AST, 347; albumin, 32.3 g⁄l; C-reactive protein,
107 mg/l; alpha-fetoprotein, normal; carcinoembryonic
antigen concentration test, normal; and amylase, unre-
markable. The patient’s coagulopathy parameters were as
follows: PT, 19.3 s; PT%, 43.6 %; fibrinogen, 1.4 g/l; APTT,
120.9 s; and TT, 21.3 s.
Paracentesis fluid revealed serosanguinous ascites, and
bacterial culture showed that no bacteria were present.
Enhanced computerized tomography results showed
hepatic nodular regeneration, moderate ascites, a dilated
bowel, and emboli in the portal vein and the superior
mesenteric vein that extended to the distal and tributary
veins (Fig. 1). Melena and hematemesis reoccurred after
administering coagulants including thrombase and tran-
examic acid, which were administered for a few days.
The patient was moved to transplant surgery to await a
donated liver.
Two days later, the liver from a 35-year-old deceased
male with ABO-compatibility was available, and liver
transplantation and thrombectomy were planned. After
entry into the abdominal cavity, approximately 2.5 l of
ascites was removed using suction. The abdominal cavity
was explored; the liver had several nodules, the spleen
and gall bladder had been excised, complete occlusion of
the portal vein and the superior mesenteric vein (Grade
III-IV) was found, and two segments of the proximal je-
junum were purplish-black in color. A short distal vein
arcade was fully occluded, and there was intestinal ne-
crosis with intestinal tone and no perforation (Figs. 2
and 3). Ascites culture results were negative, which sug-
gested that there was no bacterial translocation. Intra-
operative ultrasound confirmed the permeability of the
superior mesenteric artery, which had a palpable pulse.
Further histology results showed nodular hyperplasia
that excluded small cancer. Orthotopic LT was then per-
formed using a piggy-back caval anastomosis, and portal
vein eversion was then conducted to remove the thrombi
in the portal and superior mesenteric veins. These veins
were cavernous, with numerous small thrombi that were
flushed out via blood flow. Portal venous blood flow was
restored and confirmed intra-operatively using a Doppler
ultrasonic flow meter (data not shown), and 25 units of
plasma and packed red cells were transfused. Approxi-
mately 100 cm of gangrenous jejunum was subsequently
resected from Treitz’s ligament, and an end-to-end
anastomosis of the jejunum was performed to maintain
intestinal continuity. The patient recovered fully, although
a fistula occurred, which resolved upon draining.
Medications such as the following were administered:
immunosuppressive therapy to treat immune rejection,
potent broad-spectrum antibiotics to treat potential in-
fection, anti-coagulant agents to treat re-embolism, and
lamivudine and immunoglobulin to prevent hepatitis B
viral infection recurrence. The allograft functioned well,
and ALT, AST and bilirubin levels decreased daily, while
albumin levels increased. Thirteen days after OLT, a
fistula occurred in the anastomosis, and laparoscopic
Fig. 1 Computerized tomography scan showed ascites, cirrhosis,
emboli in portal vein system (arrows) Fig. 2 Appearance of the to-be excised jejunum
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surgery was performed again to allow suction and access
to the abdominal cavity. A 4-cm mushroom-shaped tube
was inserted into the near jejunum to allow drainage,
and a feeding tube was also inserted into the distal intes-
tine. After about 3 weeks, the patient was recovering
well. Seventy months after surgery, the patient’s allograft
was functioning well and his medical history has been
uneventful.
Discussion
We report the case of a cirrhosis patient with acute-on-
chronic PVT. Chronic PVT is a commonly encountered
problem in LT candidates [13], and it is characterized by
a slow progression into cavernomatosis transformation
and portal hypertension. Refractory ascites, gastrointes-
tinal bleeding and disproportional abdominal pain are
the physical findings that clinicians observe, and a diag-
nosis of chronic PVT is usually made by chance [14]. In
a patient with an acquired hypercoagulable or primary
pro-thrombotic state, chronic PVT can develop into acute
PVT because of precipitating factors including pro-
coagulants administered to treat bleeding. Acute PVT also
has no specific symptoms and signs; intestinal ischemia
and necrosis are typical clinical presentations, while ab-
dominal pain, distention, diarrhea, and bleeding are mani-
festations. However, PVT it is usually not diagnosed at the
early stage or before surgical interventions [15]. For our
patient, PVT was diagnosed during laparotomy, not pre-
transplant. If the thrombi do not resolve, ischemia and gut
necrosis will eventually ensue, resulting in peritonitis and
septic shock, which will preclude more complex liver
transplantation. Patients with cirrhosis and high-grade
PVT were shown to have low survival compared with the
patients who were PVT-free (5), and their PVT recurrence
rate is unacceptably high [16]. An explanation for why few
PVT cases have been reported in LT candidates with acute
PVT may be because perforation will probably lead to
bacterial translocation, and peritonitis or septic shock will
ensue, which will endanger the liver allograft and recipi-
ent’s life. The risk of recurrence and the mortality rate
both remain high after LT for PVT. Additionally, an organ
donor is not always available, or other patients on the
waitlist are considered to be a higher priority to receive
donor organs.
Gastrointestinal bleeding is a common complication of
PVT. There is consensus that endoscopic variceal obtu-
ration is the first-line treatment option, and that it is
beneficial to use anticoagulant drugs if the thrombus ex-
tends into the PVT and superior mesenteric vein, even
in the event of upper gastrointestinal bleeding when the
diagnosis was made. Anticoagulant use is associated with
low recurrence and high recanalization [17]. For this pa-
tient, thrombi seemed to be diffuse, and thrombectomy
was used efficiently to ensure blood flow to the liver
graft. This is a simple and useful procedure is usually
the first choice, especially for acute thrombi. In the hy-
percoagulable state, thrombi form in the small vessels
arising from the superior mesenteric vein, and predis-
posing factors involve the large veins. Thrombogenesis
initiates compression at the site of the main portal vein,
and it then extends distally to the superior mesenteric
vein [18]. Thrombi that formed in the short time when
they were loosely and sparsely adhered to the venous tu-
nica intima were flushed by blood outflow in our patient.
Michael et al. reported that phlebothrombectomy was
performed successfully in 90 % of these patients [5]. To
our knowledge, this is the first report that details treat-
ment of an LT candidate with PVT followed by acute on-
set and subsequent intestinal ischemia.
Conclusions
In conclusion, isolated resection of intestinal gangrene
without perforation that results from acute PVT may
not jeopardize liver transplantation in patients with end-
stage cirrhosis. Multidisciplinary collaborations and im-
proved imaging technology are needed to screen and
prevent rapid progression of PVT at the early stage, and
decisive and aggressive approaches are crucial for favor-
able outcomes.
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Fig. 3 H&Estaining showed necrosis in the intestinal wall
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